Database of adverse events associated with drugs and drug combinations

被引:18
作者
Poleksic, Aleksandar [1 ]
Xie, Lei [2 ,3 ]
机构
[1] Univ Northern Iowa, Dept Comp Sci, Cedar Falls, IA 50614 USA
[2] CUNY Hunter Coll, Dept Comp Sci, New York, NY 10065 USA
[3] CUNY, Grad Ctr, PhD Comp Sci Program, New York, NY 10065 USA
关键词
TRANSPLANT RECIPIENT; CYCLOSPORINE; BOSENTAN; SAFETY; ETOPOSIDE; SIROLIMUS; WARFARIN;
D O I
10.1038/s41598-019-56525-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Due to the aging world population and increasing trend in clinical practice to treat patients with multiple drugs, adverse events (AEs) are becoming a major challenge in drug discovery and public health. In particular, identifying AEs caused by drug combinations remains a challenging task. Clinical trials typically focus on individual drugs rather than drug combinations and animal models are unreliable. An added difficulty is the combinatorial explosion in the number of possible combinations that can be made using the increasingly large set of FDA approved chemicals. We present a statistical and computational technique for identifying AEs caused by two-drug combinations. Taking advantage of the large and increasing data deposited in FDA's postmarketing reports, we demonstrate that the task of predicting AEs for 2-drug combinations is amenable to the Likelihood Ratio Test (LRT). Our pAERS database constructed with LRT contains almost 77 thousand associations between pairs of drugs and corresponding AEs caused solely by drug-drug interactions (DDIs). The DDIs stored in pAERS complement the existing data sets. Due to our stringent statistical test, we expect many of the associations in pAERS to be unrecorded or poorly documented in the literature.
引用
收藏
页数:9
相关论文
共 50 条
  • [32] Identifying Adverse Drug Reactions Associated with Drug-Drug Interactions Data Mining of a Spontaneous Reporting Database in Italy
    Leone, Roberto
    Magro, Lara
    Moretti, Llgo
    Cutroneo, Paola
    Moschini, Martina
    Motola, Domenico
    Tuccori, Marco
    Conforti, Anita
    DRUG SAFETY, 2010, 33 (08) : 667 - 675
  • [33] Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma
    Nadeem, Omar
    Ailawadhi, Sikander
    Khouri, Jack
    Williams, Louis
    Catamero, Donna
    Maples, Kathryn
    Berdeja, Jesus
    CANCERS, 2024, 16 (05)
  • [34] Search of official nationwide database in Japan for adverse events associated with disease-modifying antirheumatic drug therapies: focus on therapies in combination with methotrexate
    Inokuma, Shigeko
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (04) : 573 - 580
  • [35] Mtor inhibitors associated with higher cardiovascular adverse events-A large population database analysis
    Nguyen, Vi N.
    Abagyan, Ruben
    Tsunoda, Shirley M.
    CLINICAL TRANSPLANTATION, 2021, 35 (04)
  • [36] Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Subeesh, Viswam
    Maheswari, Eswaran
    Singh, Hemendra
    Beulah, Thomas Elsa
    Swaroop, Ann Mary
    CURRENT DRUG SAFETY, 2019, 14 (01) : 21 - 26
  • [37] Comparative Study of Adverse Drug Reactions Associated with Filgrastim and Pegfilgrastim Using the EudraVigilance Database
    Rastogi, Shruti
    Kalaiselvan, Vivekanandan
    Bin Jardan, Yousef A.
    Zameer, Saima
    Sarwat, Maryam
    BIOLOGY-BASEL, 2022, 11 (02):
  • [38] Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database
    Shimada, Kazuyo
    Hasegawa, Shiori
    Nakao, Satoshi
    Mukai, Ririka
    Sasaoka, Sayaka
    Ueda, Natsumi
    Kato, Yamato
    Abe, Junko
    Mori, Takayuki
    Yoshimura, Tomoaki
    Kinosada, Yasutomi
    Nakamura, Mitsuhiro
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (09): : 1295 - 1303
  • [40] Intensive monitoring of adverse drug events associated with the use of new glucose-lowering drugs: results from an inception cohort study in Portugal
    Torre, C.
    Guerreiro, J.
    Longo, P.
    Raposo, J. F.
    Leufkens, H.
    Martins, A. P.
    DIABETIC MEDICINE, 2020, 37 (04) : 648 - 656